Previous studies have shown that various microRNA targeting CTGF enhanced the expression of E-cadherin in diverse cancers including colorectal cancer, hepatocellular carcinoma, esophageal squamous cell carcinoma [47–49]. Here, CCN2 is linked to cancer.